Workflow
医汇集团(08161) - 2025 - 中期业绩
MEDINET GROUPMEDINET GROUP(HK:08161)2024-11-25 12:43

Financial Performance - For the six months ended September 30, 2024, the company's revenue was approximately HKD 57.9 million, a decrease of about HKD 208,000 compared to the same period in 2023[5]. - The net loss attributable to owners of the company for the period was approximately HKD 916,000, compared to a net loss of approximately HKD 2.3 million for the same period in 2023[5]. - Total comprehensive loss for the six months ended September 30, 2024, was HKD 984,000, compared to HKD 2.3 million for the same period in 2023[9]. - Basic and diluted loss per share for the period was HKD 2.202, compared to HKD 5.457 for the same period in 2023[9]. - Total revenue for the six months ended September 30, 2024, was HKD 61,830,000, a decrease from HKD 58,083,000 for the same period in 2023[39]. - The company reported a pre-tax loss of HKD 2,283,000 for the six months ended September 30, 2024, compared to a pre-tax loss of HKD 737,000 for the same period in 2023[45]. - Basic loss per share for the six months ended September 30, 2024, was HKD (916), compared to HKD (2,270) for the same period in 2023[50]. - The company experienced a loss from operations of HKD (1,127,000) for the six months ended September 30, 2024, compared to a profit of HKD 501,000 in the previous year[39]. Revenue Breakdown - The external revenue from dental services was HKD 26,791,000, while medical services generated HKD 31,292,000 for the six months ended September 30, 2024[39]. - Revenue from providing medical solutions to corporate clients increased by approximately 9.5% to HKD 20.9 million from HKD 19.1 million in the previous period[69]. - Revenue from self-paying patients for medical services increased by approximately 5.5% to HKD 12.8 million from HKD 12.2 million in the previous period[70]. - Revenue from providing dental solutions to corporate clients increased by approximately 28.2% to HKD 2.3 million from HKD 1.8 million in the previous period[70]. - Revenue from self-paying patients for dental services decreased by approximately 12.8% to HKD 21.8 million from HKD 25.0 million in the previous period[70]. - Revenue from medical plans for insurance companies was HKD 14,767,000, slightly down from HKD 15,152,000 in the previous year[42]. Assets and Liabilities - As of September 30, 2024, total assets amounted to HKD 15,390 million, an increase from HKD 12,777 million as of March 31, 2024, representing a growth of approximately 20.5%[10]. - Total current liabilities increased to HKD 37,595 million as of September 30, 2024, up from HKD 35,771 million as of March 31, 2024, reflecting a rise of 5.1%[10]. - The company’s non-current liabilities, specifically lease liabilities, increased to HKD 4,514 million as of September 30, 2024, from HKD 2,802 million as of March 31, 2024, marking a rise of 60.9%[12]. - The total equity attributable to owners of the company decreased to HKD 2,648 million as of September 30, 2024, down from HKD 3,632 million as of March 31, 2024, a decline of 27.1%[15]. - The company’s total liabilities increased to HKD 37,595 million as of September 30, 2024, compared to HKD 35,771 million as of March 31, 2024, reflecting a growth of 5.1%[10]. Cash Flow - The company reported a net cash inflow from operating activities of HKD 2,107 million for the six months ended September 30, 2024, compared to HKD 770 million for the same period in 2023, indicating a significant increase of 173.5%[19]. - The company’s cash and cash equivalents decreased to HKD 15,009 million as of September 30, 2024, down from HKD 17,325 million as of March 31, 2024, a decline of 13.4%[19]. - The net cash used in financing activities was HKD 4,374 million for the six months ended September 30, 2024, compared to a net cash inflow of HKD 4,848 million for the same period in 2023[19]. Operational Highlights - The company incurred total employee costs of HKD 18,727,000 for the six months ended September 30, 2024, an increase from HKD 17,586,000 in the previous year[45]. - Employee costs increased by approximately 6.5% to HKD 18.7 million from HKD 17.6 million in the previous period, mainly due to an increase in the number of employees and annual salary adjustments[74]. - The company spent approximately HKD 134,000 on the purchase of property, plant, and equipment during the period, significantly lower than HKD 1,329,000 for the six months ended September 30, 2023[51]. - Medical and dental professional service expenses slightly decreased by 1.0% to approximately HKD 25.0 million from HKD 25.3 million in the previous period[73]. - Cost of medical and dental supplies significantly reduced by approximately 29.4% from about HKD 5.1 million to approximately HKD 3.6 million[76]. - Other expenses decreased by approximately 13.1% from about HKD 7.2 million to approximately HKD 6.2 million, primarily due to cost control measures[79]. Corporate Governance - The board of directors does not recommend the payment of an interim dividend for the period[5]. - The Audit Committee was established on May 19, 2016, in accordance with GEM Listing Rules, consisting of three independent non-executive directors[112]. - The Audit Committee's main responsibilities include reviewing and supervising internal controls and risk management systems[112]. - The executive directors as of the announcement date are Mr. Chan Chi Wai and Ms. Jiang Jie, with independent non-executive directors including Mr. Leung Po Han, Mr. Wong Wai Leung, and Mr. Ng Wai Hung[114]. Shareholder Information - The issued share capital of the company as of September 30, 2024, was HKD 10,400,000, with 41,600,000 shares outstanding[83]. - As of September 30, 2024, Medinet International Limited holds 23,400,000 shares, representing 56.25% of the company's issued share capital[99]. - NSD Capital Limited, Convoy Asset Management Limited, Favour Sino Holdings Limited, and Convoy (BVI) Limited each hold 7,800,000 shares, accounting for 18.75% of the company's issued share capital[99]. - The company has not purchased, sold, or redeemed any of its listed securities during the reporting period[104].